{"transactions":[{"id":686226,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, CFO & Treasurer"}}],"security":"Common Stock","published_at":"2026-08-17T19:17:31.000Z","date":"2026-08-14","kind":"sale","planned":false,"acquired":false,"shares":715,"price":28.549,"value":20412.535,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction."}],"balance_after":210112,"source":{"system":"sec-edgar","filing":"0001628280-26-057327","document":"wk-form4_1786994249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000162828026057327/wk-form4_1786994249.xml","form_type":"4"}},{"id":771952,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-20T01:00:07.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 19, 2027 or (b) the date of the 2027 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 30,000 restricted stock units."}],"balance_after":74593,"source":{"system":"sec-edgar","filing":"0001193125-26-231462","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478716/000119312526231462/ownership.xml","form_type":"4"}},{"id":863760,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, CFO & Treasurer"}}],"security":"Common Stock","published_at":"2026-03-04T23:47:45.000Z","date":"2026-03-03","kind":"sale","planned":false,"acquired":false,"shares":6316,"price":37.7756,"value":238590.6896,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction."}],"balance_after":210827,"source":{"system":"sec-edgar","filing":"0001628280-26-014890","document":"wk-form4_1772668063.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/784199/000162828026014890/wk-form4_1772668063.xml","form_type":"4"}},{"id":863759,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, CFO & Treasurer"}}],"security":"Common Stock","published_at":"2026-03-04T23:47:45.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":40874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance stock units granted on February 28, 2025. One third (1/3) were issued on March 2, 2026. The remaining shares earned in connection with the February 2025 grant will be eligible to vest and be issued as follows: one third (1/3) on February 28, 2027; and one third (1/3) on February 28, 2028, assuming employment on the relevant vesting date."}],"balance_after":217143,"source":{"system":"sec-edgar","filing":"0001628280-26-014890","document":"wk-form4_1772668063.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000162828026014890/wk-form4_1772668063.xml","form_type":"4"}},{"id":871808,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, CFO & Treasurer"}}],"security":"Common Stock","published_at":"2026-03-03T19:51:51.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":5178,"price":38.0249,"value":196892.9322,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction."}],"balance_after":176269,"source":{"system":"sec-edgar","filing":"0001628280-26-013676","document":"wk-form4_1772567508.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000162828026013676/wk-form4_1772567508.xml","form_type":"4"}},{"id":883107,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, CFO & Treasurer"}}],"security":"Common Stock","published_at":"2026-02-25T22:31:54.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":37482,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of restricted stock that vest 33 1/3% per year beginning on the first anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan."}],"balance_after":181447,"source":{"system":"sec-edgar","filing":"0001628280-26-011825","document":"wk-form4_1772058711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/784199/000162828026011825/wk-form4_1772058711.xml","form_type":"4"}},{"id":883106,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, CFO & Treasurer"}}],"security":"Common Stock","published_at":"2026-02-25T22:31:54.000Z","date":"2026-02-24","kind":"sale","planned":false,"acquired":false,"shares":4485,"price":35.693,"value":160083.105,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction."}],"balance_after":143965,"source":{"system":"sec-edgar","filing":"0001628280-26-011825","document":"wk-form4_1772058711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/784199/000162828026011825/wk-form4_1772058711.xml","form_type":"4"}},{"id":883105,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COO, CFO & Treasurer"}}],"security":"Common Stock","published_at":"2026-02-25T22:31:54.000Z","date":"2026-02-23","kind":"sale","planned":false,"acquired":false,"shares":4981,"price":37.588,"value":187225.828,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction."}],"balance_after":148450,"source":{"system":"sec-edgar","filing":"0001628280-26-011825","document":"wk-form4_1772058711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000162828026011825/wk-form4_1772058711.xml","form_type":"4"}},{"id":1138937,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-21T21:30:13.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":23917,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 20, 2026 or (b) the date of the 2026 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 24,861 restricted stock units."}],"balance_after":44593,"source":{"system":"sec-edgar","filing":"0000950170-25-075893","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478716/000095017025075893/ownership.xml","form_type":"4"}},{"id":1216467,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, CFO"}}],"security":"Common Stock","published_at":"2025-03-10T21:08:36.000Z","date":"2025-03-06","kind":"sale","planned":false,"acquired":false,"shares":4909,"price":24.8042,"value":121763.8178,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction."}],"balance_after":153431,"source":{"system":"sec-edgar","filing":"0000784199-25-000053","document":"wk-form4_1741640907.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419925000053/wk-form4_1741640907.xml","form_type":"4"}},{"id":1216466,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, CFO"}}],"security":"Common Stock","published_at":"2025-03-10T21:08:36.000Z","date":"2025-03-06","kind":"grant","planned":false,"acquired":true,"shares":48100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents performance stock units granted on February 23, 2024. One third (1/3) were issued on March 6, 2025. The remaining shares earned in connection with the February 2024 grant will be eligible to vest and be issued as follows: one third (1/3) on February 23, 2026; and one third (1/3) on February 23, 2027, assuming employment on the relevant vesting date."}],"balance_after":158340,"source":{"system":"sec-edgar","filing":"0000784199-25-000053","document":"wk-form4_1741640907.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419925000053/wk-form4_1741640907.xml","form_type":"4"}},{"id":1233170,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, CFO"}}],"security":"Common Stock","published_at":"2025-03-04T19:56:20.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":34435,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock that vest 33 1/3% per year beginning on the first anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan."}],"balance_after":110240,"source":{"system":"sec-edgar","filing":"0000784199-25-000031","document":"wk-form4_1741118173.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419925000031/wk-form4_1741118173.xml","form_type":"4"}},{"id":1244508,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, CFO"}}],"security":"Common Stock","published_at":"2025-02-26T18:50:45.000Z","date":"2025-02-24","kind":"sale","planned":false,"acquired":false,"shares":3259,"price":27.306,"value":88990.254,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction."}],"balance_after":75805,"source":{"system":"sec-edgar","filing":"0000784199-25-000016","document":"wk-form4_1740595839.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419925000016/wk-form4_1740595839.xml","form_type":"4"}},{"id":1400096,"issuer":{"id":87270,"kind":"organization","name":"VAPOTHERM INC","symbol":"VAPO"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-24T18:04:13.000Z","date":"2024-09-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1089,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option, which provided for vesting in full on the earlier of the first anniversary of the date of grant or the date of the Company's 2023 annual meeting of stockholders, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Company common stock underlying the option, multiplied by (b) the excess, if any, of $2.18 over the per share exercise price of such option, which cash payment was $0.00 since this option had an exercise price that exceeded $2.18."}],"balance_after":0,"derivative":{"exercise_price":18.48,"expiration_date":"2032-07-27","underlying":"Common Stock","underlying_shares":1089},"source":{"system":"sec-edgar","filing":"0001235802-24-000075","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478716/000123580224000075/primary_doc.xml","form_type":"4"}},{"id":1400095,"issuer":{"id":87270,"kind":"organization","name":"VAPOTHERM INC","symbol":"VAPO"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-24T18:04:13.000Z","date":"2024-09-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1781,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option, which provided for vesting in thirds over three years on January 29, 2021, January 29, 2022 and January 29, 2023, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Company common stock underlying the option, multiplied by (b) the excess, if any, of $2.18 over the per share exercise price of such option, which cash payment was $0.00 since this option had an exercise price that exceeded $2.18."}],"balance_after":0,"derivative":{"exercise_price":84.8,"expiration_date":"2030-01-29","underlying":"Common Stock","underlying_shares":1781},"source":{"system":"sec-edgar","filing":"0001235802-24-000075","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478716/000123580224000075/primary_doc.xml","form_type":"4"}},{"id":1400094,"issuer":{"id":87270,"kind":"organization","name":"VAPOTHERM INC","symbol":"VAPO"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-24T18:04:13.000Z","date":"2024-09-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3000,"price":2.18,"value":6540.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The restricted stock unit awards, which these shares were subject to, were canceled in the merger in exchange for a cash payment of $2.18 per underlying share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001235802-24-000075","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478716/000123580224000075/primary_doc.xml","form_type":"4"}},{"id":1400093,"issuer":{"id":87270,"kind":"organization","name":"VAPOTHERM INC","symbol":"VAPO"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-24T18:04:13.000Z","date":"2024-09-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":22485,"price":2.18,"value":49017.3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to an Agreement and Plan of Merger, dated as of June 17, 2024, among Veronica Holdings, LLC, Veronica Intermediate Holdings, LLC, Veronica Merger Sub, Inc. and Vapotherm, Inc. (Company), in exchange for a cash payment of $2.18 per share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001235802-24-000075","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478716/000123580224000075/primary_doc.xml","form_type":"4"}},{"id":1505403,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-22T21:30:14.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":33260,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option will vest in 12 substantially equal monthly installments, commencing on June 21, 2024, such that the stock option will be fully vested and exercisable on the earlier of (a) May 21, 2025, or (b) the date of the 2025 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date."}],"balance_after":33260,"derivative":{"exercise_price":4.97,"expiration_date":"2034-05-21","underlying":"Common Stock","underlying_shares":33260},"source":{"system":"sec-edgar","filing":"0000950170-24-063613","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478716/000095017024063613/ownership.xml","form_type":"4"}},{"id":1505402,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-22T21:30:14.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":15091,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 21, 2025 or (b) the date of the 2025 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 18,788 restricted stock units."}],"balance_after":20676,"source":{"system":"sec-edgar","filing":"0000950170-24-063613","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478716/000095017024063613/ownership.xml","form_type":"4"}},{"id":1621032,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, CFO"}}],"security":"Common Stock","published_at":"2024-02-26T23:14:04.000Z","date":"2024-02-23","kind":"grant","planned":false,"acquired":true,"shares":37000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of restricted stock that vest 33 1/3% per year beginning on the first anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan."}],"balance_after":79064,"source":{"system":"sec-edgar","filing":"0000784199-24-000055","document":"wk-form4_1708989230.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419924000055/wk-form4_1708989230.xml","form_type":"4"}},{"id":1692228,"issuer":{"id":87270,"kind":"organization","name":"VAPOTHERM INC","symbol":"VAPO"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-03T21:17:16.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":10,"value":60000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award granted under the Vapotherm, Inc. Amended and Restated 2018 Equity Incentive Plan in lieu of director cash retainers for 2024.  The restricted stock unit award will vest in four nearly equal installments on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock unit award granted under the Vapotherm, Inc. Amended and Restated 2018 Equity Incentive Plan in lieu of director cash retainers for 2024.  The restricted stock unit award will vest in four nearly equal installments on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 8,625 shares that will be issued over time upon the vesting and settlement of restricted stock unit awards."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On August 18, 2023, a 1-for-8 reverse split of the common stock of Vapotherm, Inc. occurred resulting in a decrease in the number of shares held by the reporting person.  In addition, proportionate adjustments have been made to the reporting person's outstanding equity awards, including the number of restricted stock units as reflected on this Form 4 and described in footnote (2) to this Form 4, to reflect the 1-for-8 reverse stock split."}],"balance_after":25485,"source":{"system":"sec-edgar","filing":"0001235802-24-000007","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478716/000123580224000007/primary_doc.xml","form_type":"4"}},{"id":1718496,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-08T14:16:45.000Z","date":"2023-12-06","kind":"grant","planned":false,"acquired":true,"shares":93633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date."}],"balance_after":93633,"derivative":{"exercise_price":17.83,"exercise_date":"2024-12-06","expiration_date":"2030-12-06","underlying":"Common Stock","underlying_shares":93633},"source":{"system":"sec-edgar","filing":"0000784199-23-000161","document":"wk-form4_1702044996.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419923000161/wk-form4_1702044996.xml","form_type":"4"}},{"id":1718495,"issuer":{"id":4767,"kind":"organization","name":"ARTIVION, INC.","symbol":"AORT"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, CFO"}}],"security":"Common Stock","published_at":"2023-12-08T14:16:45.000Z","date":"2023-12-06","kind":"grant","planned":false,"acquired":true,"shares":42064,"price":17.83,"value":750001.12,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents shares of restricted stock that vest on the third anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan."}],"balance_after":42064,"source":{"system":"sec-edgar","filing":"0000784199-23-000161","document":"wk-form4_1702044996.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/784199/000078419923000161/wk-form4_1702044996.xml","form_type":"4"}},{"id":1821450,"issuer":{"id":87270,"kind":"organization","name":"VAPOTHERM INC","symbol":"VAPO"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-28T20:31:12.000Z","date":"2023-07-26","kind":"grant","planned":false,"acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This restricted stock unit was granted under the 2018 Equity Plan and will vest in full on the earlier of the first anniversary of the date of grant or the Issuer's 2024 annual meeting of stockholders, subject to the Reporting Person's continued service as a director of the Issuer through the vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 27,000 shares that will be issued over time upon the vesting and settlement of restricted stock unit awards."}],"balance_after":155887,"source":{"system":"sec-edgar","filing":"0001235802-23-000079","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478716/000123580223000079/primary_doc.xml","form_type":"4"}},{"id":1878025,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-26T01:00:28.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":6305,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option will vest in 12 substantially equal monthly installments, commencing on June 23, 2023, such that the stock option will be fully vested and exercisable on the earlier of (a) May 23, 2024, or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date."}],"balance_after":6305,"derivative":{"exercise_price":26.34,"expiration_date":"2033-05-23","underlying":"Common Stock","underlying_shares":6305},"source":{"system":"sec-edgar","filing":"0001209191-23-032352","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478716/000120919123032352/doc4.xml","form_type":"4"}},{"id":1878024,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-26T01:00:28.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":2753,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 23, 2024 or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date.  The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,585 RSUs."}],"balance_after":5585,"source":{"system":"sec-edgar","filing":"0001209191-23-032352","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478716/000120919123032352/doc4.xml","form_type":"4"}},{"id":2016280,"issuer":{"id":87270,"kind":"organization","name":"VAPOTHERM INC","symbol":"VAPO"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant","published_at":"2023-02-14T22:47:48.000Z","date":"2023-02-10","kind":"purchase","acquired":true,"shares":95238,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"$1.05 per unit, each unit consisted of one share of common stock and a warrant to purchase one share of common stock."}],"balance_after":95238,"derivative":{"exercise_price":1.17,"exercise_date":"2023-02-10","expiration_date":"2028-02-10","underlying":"Common Stock","underlying_shares":95238},"source":{"system":"sec-edgar","filing":"0001235802-23-000026","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478716/000123580223000026/primary_doc.xml","form_type":"4"}},{"id":2016279,"issuer":{"id":87270,"kind":"organization","name":"VAPOTHERM INC","symbol":"VAPO"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-14T22:47:48.000Z","date":"2023-02-10","kind":"purchase","acquired":true,"shares":95238,"price":1.05,"value":99999.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"$1.05 per unit, each unit consisted of one share of common stock and a warrant to purchase one share of common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 12,000 shares that will be issued over time upon the vesting and settlement of restricted stock unit awards."}],"balance_after":134887,"source":{"system":"sec-edgar","filing":"0001235802-23-000026","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478716/000123580223000026/primary_doc.xml","form_type":"4"}},{"id":2067325,"issuer":{"id":87270,"kind":"organization","name":"VAPOTHERM INC","symbol":"VAPO"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-04T23:38:14.000Z","date":"2023-01-02","kind":"grant","acquired":true,"shares":12000,"price":2.7,"value":32400.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award granted under the Vapotherm, Inc. Amended and Restated 2018 Equity Incentive Plan in lieu of director cash retainers for 2023.  The restricted stock unit award will vest in four nearly equal installments on each of March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock unit award granted under the Vapotherm, Inc. Amended and Restated 2018 Equity Incentive Plan in lieu of director cash retainers for 2023.  The restricted stock unit award will vest in four nearly equal installments on each of March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 12,000 shares that will be issued over time upon the vesting and settlement of restricted stock unit awards."}],"balance_after":39649,"source":{"system":"sec-edgar","filing":"0001235802-23-000011","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478716/000123580223000011/primary_doc.xml","form_type":"4"}},{"id":2144488,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-04T23:00:10.000Z","date":"2022-10-01","kind":"grant","acquired":true,"shares":19439,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The stock option vests over three years in substantially equal monthly installments with the first vesting to occur on November 1, 2022 such that the stock option will be fully vested and exercisable on October 1, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests over three years in substantially equal monthly installments with the first vesting to occur on November 1, 2022 such that the stock option will be fully vested and exercisable on October 1, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date."}],"balance_after":19439,"derivative":{"exercise_price":22.07,"expiration_date":"2032-10-01","underlying":"Common Stock","underlying_shares":19439},"source":{"system":"sec-edgar","filing":"0001209191-22-052525","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478716/000120919122052525/doc4.xml","form_type":"4"}},{"id":2144487,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-04T23:00:10.000Z","date":"2022-10-01","kind":"grant","acquired":true,"shares":2832,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs will vest in three equal yearly installments starting October 1,  2023 such that the RSUs will be fully vested on October 1, 2025 subject to Reporting Person's providing continued service to Issuer through each vesting date."}],"balance_after":2832,"source":{"system":"sec-edgar","filing":"0001209191-22-052525","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478716/000120919122052525/doc4.xml","form_type":"4"}},{"id":2194444,"issuer":{"id":87270,"kind":"organization","name":"VAPOTHERM INC","symbol":"VAPO"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-08-04T20:27:07.000Z","date":"2022-07-27","kind":"grant","acquired":true,"shares":8717,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted under the Vapotherm, Inc.'s 2018 Equity Incentive Plan (as amended from time to time) and will vest in full on the earlier of the first anniversary of the date of grant or the Issuer's 2023 annual meeting of stockholders, subject to the Reporting Person's continued service as a director of the Issuer through the vesting date."}],"balance_after":8717,"derivative":{"exercise_price":2.31,"expiration_date":"2032-07-27","underlying":"Common Stock","underlying_shares":8717},"source":{"system":"sec-edgar","filing":"0001235802-22-000084","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478716/000123580222000084/primary_doc.xml","form_type":"4"}},{"id":2273492,"issuer":{"id":87270,"kind":"organization","name":"VAPOTHERM INC","symbol":"VAPO"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-13T00:57:29.000Z","date":"2022-05-12","kind":"purchase","acquired":true,"shares":15673,"price":3.18,"value":49840.14,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $3.185 to $3.19, inclusive.  The reporting person undertakes to provide to Vapotherm, Inc., any security holder of Vapotherm, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,392 shares that will be issued over time subject to restricted stock units granted under the Vapotherm, Inc. 2018 Equity Incentive Plan."}],"balance_after":27649,"source":{"system":"sec-edgar","filing":"0001235802-22-000061","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478716/000123580222000061/primary_doc.xml","form_type":"4"}},{"id":2625852,"issuer":{"id":87270,"kind":"organization","name":"VAPOTHERM INC","symbol":"VAPO"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-23T20:21:17.000Z","date":"2021-07-21","kind":"grant","acquired":true,"shares":5392,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This annual award in the form of restricted stock units was granted under the Vapotherm, Inc. 2018 Equity Incentive Plan pursuant to the terms of the Vapotherm, Inc. Amended and Restated Non-Employee Director Compensation Policy.  The restricted stock units are eligible to vest in full on the earlier of the first anniversary of the date of grant or the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person's continued service as a director of the Issuer through the vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,392 shares that will be issued over time subject to restricted stock units granted under the Vapotherm, Inc. 2018 Equity Incentive Plan."}],"balance_after":11976,"source":{"system":"sec-edgar","filing":"0001235802-21-000084","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478716/000123580221000084/primary_doc.xml","form_type":"4"}},{"id":2981230,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Fin & Op Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T17:03:37.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":18262,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":29.06,"expiration_date":"2024-05-13","underlying":"Ordinary Shares","underlying_shares":18262},"source":{"system":"sec-edgar","filing":"0001686266-20-000015","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000168626620000015/primary_doc.xml","form_type":"4"}},{"id":2981229,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Fin & Op Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T17:03:37.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":10190,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":21.24,"expiration_date":"2026-07-19","underlying":"Ordinary Shares","underlying_shares":10190},"source":{"system":"sec-edgar","filing":"0001686266-20-000015","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000168626620000015/primary_doc.xml","form_type":"4"}},{"id":2981228,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Fin & Op Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T17:03:37.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":14125,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":27.86,"expiration_date":"2027-07-25","underlying":"Ordinary Shares","underlying_shares":14125},"source":{"system":"sec-edgar","filing":"0001686266-20-000015","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000168626620000015/primary_doc.xml","form_type":"4"}},{"id":2981227,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Fin & Op Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T17:03:37.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":25013,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":24.49,"expiration_date":"2028-07-24","underlying":"Ordinary Shares","underlying_shares":25013},"source":{"system":"sec-edgar","filing":"0001686266-20-000015","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000168626620000015/primary_doc.xml","form_type":"4"}},{"id":2981226,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Fin & Op Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T17:03:37.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":53614,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a \"Wright Stock Option\") that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time, and at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":27.84,"expiration_date":"2029-07-26","underlying":"Ordinary Shares","underlying_shares":53614},"source":{"system":"sec-edgar","filing":"0001686266-20-000015","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000168626620000015/primary_doc.xml","form_type":"4"}},{"id":2981225,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Fin & Op Officer"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-11-13T17:03:37.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":61980,"price":30.75,"value":1905885.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"In connection with the Offer, each performance share unit in respect of Shares (a \"Wright PSU\") that was outstanding and unvested immediately prior to the Acceptance Time vested in full at the Acceptance Time, and, at the Closing, was cancelled in exchange for a cash payment equal to the product of (a) $30.75 multiplied by (b) the total number of Shares subject to such Wright PSU as of immediately prior to the Acceptance Time determined based on the maximum achievement of the applicable performance condition, without interest and less applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001686266-20-000015","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000168626620000015/primary_doc.xml","form_type":"4"}},{"id":2981224,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Fin & Op Officer"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-11-13T17:03:37.000Z","date":"2020-11-11","kind":"grant","acquired":true,"shares":61980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"In connection with the Offer, each performance share unit in respect of Shares (a \"Wright PSU\") that was outstanding and unvested immediately prior to the Acceptance Time vested in full at the Acceptance Time, and, at the Closing, was cancelled in exchange for a cash payment equal to the product of (a) $30.75 multiplied by (b) the total number of Shares subject to such Wright PSU as of immediately prior to the Acceptance Time determined based on the maximum achievement of the applicable performance condition, without interest and less applicable withholding taxes."}],"balance_after":61980,"source":{"system":"sec-edgar","filing":"0001686266-20-000015","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000168626620000015/primary_doc.xml","form_type":"4"}},{"id":2981223,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Fin & Op Officer"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-11-13T17:03:37.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":26227,"price":30.75,"value":806480.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"See Exhibit 99.1."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001686266-20-000015","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000168626620000015/primary_doc.xml","form_type":"4"}},{"id":2981222,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Fin & Op Officer"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-11-13T17:03:37.000Z","date":"2020-11-11","kind":"disposition_to_issuer","acquired":false,"shares":43850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents Shares issuable upon vesting of the 2020 RSUs which did not vest at the Acceptance Time and were cancelled and forfeited at the Closing for no Offer Consideration or other consideration.  See note (5) below for the treatment of the Wright 2020 RSUs in connection with the Offer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 22,584 Shares issuable upon vesting of the Wright RSUs and 3,643 Shares issuable upon vesting of the 2020 RSUs.  See Note (5) below for the treatment of Wright RSUs and Wright 2020 RSUs in connection with the Offer."}],"balance_after":26227,"source":{"system":"sec-edgar","filing":"0001686266-20-000015","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000168626620000015/primary_doc.xml","form_type":"4"}},{"id":2981221,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Fin & Op Officer"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-11-13T17:03:37.000Z","date":"2020-11-11","kind":"other","acquired":false,"shares":116976,"price":30.75,"value":3597012.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 4, 2019, Wright Medical Group N.V. (the \"Issuer\") entered into a purchase agreement (the \"Purchase Agreement\") with Stryker Corporation and its subsidiary, Stryker B.V. (the \"Purchaser\").  Pursuant to the terms of the Purchase Agreement, the Purchaser commenced a tender offer for all the outstanding ordinary shares, par value EUR0.03 per share (\"Shares\"), of the Issuer (the \"Offer\"), and, on November 11, 2020 (the \"Acceptance Time\"), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer as of the Acceptance Time, including 116,976 Shares tendered by the reporting person, in exchange for a cash payment equal to $30.75 per Share, without interest and less applicable withholding taxes (the \"Offer Consideration\"), which Offer Consideration will be paid as promptly as practicable following the Closing (as defined in the Purchase Agreement)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 22,584 Shares issuable upon vesting of restricted stock units in respect of Shares (collectively, \"Wright RSUs\") and 47,493 Shares issuable upon vesting of Wright RSUs granted on July 23, 2020 (the \"2020 RSUs\").  See note (5) below for the treatment of such Wright RSUs and Wright 2020 RSUs in connection with the Offer."}],"balance_after":70077,"source":{"system":"sec-edgar","filing":"0001686266-20-000015","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000168626620000015/primary_doc.xml","form_type":"4"}},{"id":3039168,"issuer":{"id":87270,"kind":"organization","name":"VAPOTHERM INC","symbol":"VAPO"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-03T20:01:53.000Z","date":"2020-09-02","kind":"grant","acquired":true,"shares":2466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Annual award in the form of shares of common stock pursuant to the Issuer's amended and restated Non-Employee Director Compensation Policy, granted in consideration of the Reporting Person's service on the Issuer's Board of Directors and prorated from his appointment to the Board of Directors on January 29, 2020 through the Issuer's annual meeting on June 23, 2020."}],"balance_after":6584,"source":{"system":"sec-edgar","filing":"0001562180-20-005830","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478716/000156218020005830/primarydocument.xml","form_type":"4"}},{"id":3039167,"issuer":{"id":87270,"kind":"organization","name":"VAPOTHERM INC","symbol":"VAPO"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-03T20:01:53.000Z","date":"2020-09-01","kind":"grant","acquired":true,"shares":4118,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual award in the form of restricted stock units (\"RSUs\") granted to the Reporting Person under the Issuer's amended and restated Non-Employee Director Compensation Policy.  This RSU is eligible to vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's 2021 annual meeting of stockholders"}],"balance_after":4118,"source":{"system":"sec-edgar","filing":"0001562180-20-005830","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478716/000156218020005830/primarydocument.xml","form_type":"4"}},{"id":3052332,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Finan./Op. Officer"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-08-19T16:24:20.000Z","date":"2020-08-17","kind":"sale","acquired":false,"shares":4421,"price":30.1349,"value":133226.3929,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $30.13 to $30.135, inclusive.  The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group  N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 9,510 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 60,567 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":187053,"source":{"system":"sec-edgar","filing":"0001235802-20-000105","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580220000105/primary_doc.xml","form_type":"4"}},{"id":3075560,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial & Op. Off"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-07-27T16:06:02.000Z","date":"2020-07-23","kind":"grant","acquired":true,"shares":47493,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These ordinary shares will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan.  The grant agreement contemplates that the shares will vest pro rata through the closing of the previously announced Stryker transaction, and shares unvested at closing will be cancelled."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 15,631 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 64,925 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":191474,"source":{"system":"sec-edgar","filing":"0001235802-20-000082","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580220000082/primary_doc.xml","form_type":"4"}},{"id":3095191,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Finan./Op. Officer"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-07-01T18:41:37.000Z","date":"2020-06-30","kind":"sale","acquired":false,"shares":9137,"price":29.6303,"value":270732.0511,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of performance share unit awards."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $29.61 to $29.654, inclusive.  The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 15,631 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 17,432 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":143981,"source":{"system":"sec-edgar","filing":"0001235802-20-000074","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580220000074/primary_doc.xml","form_type":"4"}},{"id":3095190,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Finan./Op. Officer"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-07-01T18:41:37.000Z","date":"2020-06-29","kind":"grant","acquired":true,"shares":21846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the payout of a performance share unit award for the June 26, 2017 - June 28, 2020 performance period under the Wright Medical Group N.V. 2017 Equity and Incentive Plan, as approved by the Issuer's Compensation Committee of its Board of Directors.  Performance share unit awards are paid in ordinary shares of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 15,631 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 17,432 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":153118,"source":{"system":"sec-edgar","filing":"0001235802-20-000074","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580220000074/primary_doc.xml","form_type":"4"}},{"id":3122032,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Finan./Op. Officer"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2020-06-04T16:19:08.000Z","date":"2020-06-02","kind":"sale","acquired":false,"shares":2236,"price":29.7345,"value":66486.342,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $29.73 to $29.7401, inclusive.  The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group  N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 15,631 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 17,432 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":131272,"source":{"system":"sec-edgar","filing":"0001235802-20-000057","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580220000057/primary_doc.xml","form_type":"4"}},{"id":3297729,"issuer":{"id":87270,"kind":"organization","name":"VAPOTHERM INC","symbol":"VAPO"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-31T00:18:10.000Z","date":"2020-01-29","kind":"grant","acquired":true,"shares":14250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in thirds over three years, on January 29, 2021, January 29, 2022 and January 29, 2023, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such vesting date."}],"balance_after":14250,"derivative":{"exercise_price":10.6,"expiration_date":"2030-01-29","underlying":"Common Stock","underlying_shares":14250},"source":{"system":"sec-edgar","filing":"0000904454-20-000104","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478716/000090445420000104/edgar.xml","form_type":"4"}},{"id":3364211,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Finan./Op. Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-11-20T17:26:39.000Z","date":"2019-11-20","kind":"exercise","acquired":false,"shares":11364,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise and sale of vested stock options in connection with 280G tax planning."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This option vested with respect to 25% of the shares on July 24, 2019 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments."}],"balance_after":25013,"derivative":{"exercise_price":24.49,"expiration_date":"2028-07-24","underlying":"Ordinary Shares","underlying_shares":11364},"source":{"system":"sec-edgar","filing":"0001235802-19-000135","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000135/primary_doc.xml","form_type":"4"}},{"id":3364210,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Finan./Op. Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-11-20T17:26:39.000Z","date":"2019-11-20","kind":"exercise","acquired":false,"shares":18122,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise and sale of vested stock options in connection with 280G tax planning."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option vested with respect to 25% of the shares on July 25, 2018 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments."}],"balance_after":14125,"derivative":{"exercise_price":27.86,"expiration_date":"2027-07-25","underlying":"Ordinary Shares","underlying_shares":18122},"source":{"system":"sec-edgar","filing":"0001235802-19-000135","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000135/primary_doc.xml","form_type":"4"}},{"id":3364209,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Finan./Op. Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-11-20T17:26:39.000Z","date":"2019-11-20","kind":"exercise","acquired":false,"shares":50605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise and sale of vested stock options in connection with 280G tax planning."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option vested with respect to 25% of the shares on July 19, 2017 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments."}],"balance_after":10190,"derivative":{"exercise_price":21.24,"expiration_date":"2026-07-19","underlying":"Ordinary Shares","underlying_shares":50605},"source":{"system":"sec-edgar","filing":"0001235802-19-000135","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000135/primary_doc.xml","form_type":"4"}},{"id":3364208,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Finan./Op. Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-11-20T17:26:39.000Z","date":"2019-11-20","kind":"exercise","acquired":false,"shares":28845,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise and sale of vested stock options in connection with 280G tax planning."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option has fully vested."}],"balance_after":0,"derivative":{"exercise_price":20.62,"expiration_date":"2025-10-13","underlying":"Ordinary Shares","underlying_shares":28845},"source":{"system":"sec-edgar","filing":"0001235802-19-000135","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000135/primary_doc.xml","form_type":"4"}},{"id":3364207,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Finan./Op. Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-11-20T17:26:39.000Z","date":"2019-11-19","kind":"exercise","acquired":false,"shares":88654,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise and sale of vested stock options in connection with 280G tax planning."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option has fully vested."}],"balance_after":28845,"derivative":{"exercise_price":20.62,"expiration_date":"2025-10-13","underlying":"Ordinary Shares","underlying_shares":88654},"source":{"system":"sec-edgar","filing":"0001235802-19-000135","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000135/primary_doc.xml","form_type":"4"}},{"id":3364206,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Finan./Op. Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-11-20T17:26:39.000Z","date":"2019-11-19","kind":"exercise","acquired":false,"shares":30602,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise and sale of vested stock options in connection with 280G tax planning."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option has fully vested."}],"balance_after":0,"derivative":{"exercise_price":23.93,"expiration_date":"2023-05-14","underlying":"Ordinary Shares","underlying_shares":30602},"source":{"system":"sec-edgar","filing":"0001235802-19-000135","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000135/primary_doc.xml","form_type":"4"}},{"id":3364205,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Finan./Op. Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-11-20T17:26:39.000Z","date":"2019-11-19","kind":"exercise","acquired":false,"shares":19557,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise and sale of vested stock options in connection with 280G tax planning."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option has fully vested."}],"balance_after":0,"derivative":{"exercise_price":20.75,"expiration_date":"2022-05-09","underlying":"Ordinary Shares","underlying_shares":19557},"source":{"system":"sec-edgar","filing":"0001235802-19-000135","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000135/primary_doc.xml","form_type":"4"}},{"id":3364204,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Finan./Op. Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-11-20T17:26:39.000Z","date":"2019-11-19","kind":"exercise","acquired":false,"shares":1924,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise and sale of vested stock options in connection with 280G tax planning."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option has fully vested."}],"balance_after":0,"derivative":{"exercise_price":17.7,"expiration_date":"2022-04-16","underlying":"Ordinary Shares","underlying_shares":1924},"source":{"system":"sec-edgar","filing":"0001235802-19-000135","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000135/primary_doc.xml","form_type":"4"}},{"id":3364203,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Finan./Op. Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-11-20T17:26:39.000Z","date":"2019-11-19","kind":"exercise","acquired":false,"shares":12528,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise and sale of vested stock options in connection with 280G tax planning."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option has fully vested."}],"balance_after":0,"derivative":{"exercise_price":15.04,"expiration_date":"2021-05-11","underlying":"Ordinary Shares","underlying_shares":12528},"source":{"system":"sec-edgar","filing":"0001235802-19-000135","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000135/primary_doc.xml","form_type":"4"}},{"id":3364202,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Finan./Op. Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-11-20T17:26:39.000Z","date":"2019-11-19","kind":"exercise","acquired":false,"shares":9635,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise and sale of vested stock options in connection with 280G tax planning."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option has fully vested."}],"balance_after":0,"derivative":{"exercise_price":17.82,"expiration_date":"2020-05-13","underlying":"Ordinary Shares","underlying_shares":9635},"source":{"system":"sec-edgar","filing":"0001235802-19-000135","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000135/primary_doc.xml","form_type":"4"}},{"id":3364201,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Finan./Op. Officer"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2019-11-20T17:26:39.000Z","date":"2019-11-20","kind":"sale","acquired":false,"shares":108936,"price":29.5025,"value":3213884.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise and sale of vested stock options in connection with 280G tax planning."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $29.47 to $29.54, inclusive.  The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,290 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 15,631 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 17,432 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":133508,"source":{"system":"sec-edgar","filing":"0001235802-19-000135","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000135/primary_doc.xml","form_type":"4"}},{"id":3364200,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Finan./Op. Officer"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2019-11-20T17:26:39.000Z","date":"2019-11-20","kind":"exercise","acquired":true,"shares":11364,"price":24.49,"value":278304.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise and sale of vested stock options in connection with 280G tax planning."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,290 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 15,631 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 17,432 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":242444,"source":{"system":"sec-edgar","filing":"0001235802-19-000135","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000135/primary_doc.xml","form_type":"4"}},{"id":3364199,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Finan./Op. Officer"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2019-11-20T17:26:39.000Z","date":"2019-11-20","kind":"exercise","acquired":true,"shares":18122,"price":27.86,"value":504878.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise and sale of vested stock options in connection with 280G tax planning."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,290 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 15,631 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 17,432 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":231080,"source":{"system":"sec-edgar","filing":"0001235802-19-000135","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000135/primary_doc.xml","form_type":"4"}},{"id":3364198,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Finan./Op. Officer"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2019-11-20T17:26:39.000Z","date":"2019-11-20","kind":"exercise","acquired":true,"shares":50605,"price":21.24,"value":1074850.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise and sale of vested stock options in connection with 280G tax planning."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,290 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 15,631 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 17,432 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":212958,"source":{"system":"sec-edgar","filing":"0001235802-19-000135","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000135/primary_doc.xml","form_type":"4"}},{"id":3364197,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Finan./Op. Officer"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2019-11-20T17:26:39.000Z","date":"2019-11-20","kind":"exercise","acquired":true,"shares":28845,"price":20.62,"value":594783.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise and sale of vested stock options in connection with 280G tax planning."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,290 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 15,631 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 17,432 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":162353,"source":{"system":"sec-edgar","filing":"0001235802-19-000135","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000135/primary_doc.xml","form_type":"4"}},{"id":3364196,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Finan./Op. Officer"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2019-11-20T17:26:39.000Z","date":"2019-11-19","kind":"sale","acquired":false,"shares":162900,"price":29.5617,"value":4815600.93,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise and sale of vested stock options in connection with 280G tax planning."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $29.53 to $29.605, inclusive.  The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,290 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 15,631 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 17,432 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":133508,"source":{"system":"sec-edgar","filing":"0001235802-19-000135","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000135/primary_doc.xml","form_type":"4"}},{"id":3364195,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Finan./Op. Officer"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2019-11-20T17:26:39.000Z","date":"2019-11-19","kind":"exercise","acquired":true,"shares":88654,"price":20.62,"value":1828045.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise and sale of vested stock options in connection with 280G tax planning."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,290 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 15,631 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 17,432 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":296408,"source":{"system":"sec-edgar","filing":"0001235802-19-000135","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000135/primary_doc.xml","form_type":"4"}},{"id":3364194,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Finan./Op. Officer"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2019-11-20T17:26:39.000Z","date":"2019-11-19","kind":"exercise","acquired":true,"shares":30602,"price":23.93,"value":732305.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise and sale of vested stock options in connection with 280G tax planning."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,290 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 15,631 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 17,432 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":207754,"source":{"system":"sec-edgar","filing":"0001235802-19-000135","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000135/primary_doc.xml","form_type":"4"}},{"id":3364193,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Finan./Op. Officer"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2019-11-20T17:26:39.000Z","date":"2019-11-19","kind":"exercise","acquired":true,"shares":19557,"price":20.75,"value":405807.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise and sale of vested stock options in connection with 280G tax planning."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,290 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 15,631 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 17,432 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":177152,"source":{"system":"sec-edgar","filing":"0001235802-19-000135","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000135/primary_doc.xml","form_type":"4"}},{"id":3364192,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Finan./Op. Officer"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2019-11-20T17:26:39.000Z","date":"2019-11-19","kind":"exercise","acquired":true,"shares":1924,"price":17.7,"value":34054.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise and sale of vested stock options in connection with 280G tax planning."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,290 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 15,631 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 17,432 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":157595,"source":{"system":"sec-edgar","filing":"0001235802-19-000135","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000135/primary_doc.xml","form_type":"4"}},{"id":3364191,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Finan./Op. Officer"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2019-11-20T17:26:39.000Z","date":"2019-11-19","kind":"exercise","acquired":true,"shares":12528,"price":15.04,"value":188421.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise and sale of vested stock options in connection with 280G tax planning."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,290 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 15,631 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 17,432 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":155671,"source":{"system":"sec-edgar","filing":"0001235802-19-000135","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000135/primary_doc.xml","form_type":"4"}},{"id":3364190,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Finan./Op. Officer"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2019-11-20T17:26:39.000Z","date":"2019-11-19","kind":"exercise","acquired":true,"shares":9635,"price":17.82,"value":171695.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Exercise and sale of vested stock options in connection with 280G tax planning."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,290 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 15,631 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 17,432 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":143143,"source":{"system":"sec-edgar","filing":"0001235802-19-000135","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000135/primary_doc.xml","form_type":"4"}},{"id":3433188,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Fin & Op Officer"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2019-08-20T16:22:28.000Z","date":"2019-08-16","kind":"sale","acquired":false,"shares":2558,"price":21.2364,"value":54322.7112,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $21.232 to $21.24, inclusive.  The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 5,290 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 15,631 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 17,432 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":133508,"source":{"system":"sec-edgar","filing":"0001235802-19-000111","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000111/primary_doc.xml","form_type":"4"}},{"id":3453179,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Fin & Op Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-07-30T16:26:39.000Z","date":"2019-07-26","kind":"grant","acquired":true,"shares":53614,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests with respect to 25% of the shares on July 26, 2020 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments."}],"balance_after":53614,"derivative":{"exercise_price":27.84,"expiration_date":"2029-07-26","underlying":"Ordinary Shares","underlying_shares":53614},"source":{"system":"sec-edgar","filing":"0001235802-19-000078","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000078/primary_doc.xml","form_type":"4"}},{"id":3453178,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Fin & Op Officer"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2019-07-30T16:26:39.000Z","date":"2019-07-26","kind":"grant","acquired":true,"shares":17432,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These ordinary shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,290 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 21,751 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 17,432 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan."}],"balance_after":136066,"source":{"system":"sec-edgar","filing":"0001235802-19-000078","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000078/primary_doc.xml","form_type":"4"}},{"id":3500503,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Chief Fin & Op Officer"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2019-06-05T16:20:23.000Z","date":"2019-06-03","kind":"sale","acquired":false,"shares":6575,"price":30.5105,"value":200606.5375,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $30.47 to $30.555, inclusive.  The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group  N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 5,290 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 21,751 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."}],"balance_after":118634,"source":{"system":"sec-edgar","filing":"0001235802-19-000048","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000048/primary_doc.xml","form_type":"4"}},{"id":3612456,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & Operations Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-03-05T16:49:32.000Z","date":"2019-03-01","kind":"exercise","acquired":false,"shares":6575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, the reporting person exercised this option, and sold the underlying shares, because the option was in the money and scheduled to expire on May 13, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option has fully vested."}],"balance_after":0,"derivative":{"exercise_price":15.01,"expiration_date":"2019-05-13","underlying":"Ordinary Shares","underlying_shares":6575},"source":{"system":"sec-edgar","filing":"0001235802-19-000022","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000022/primary_doc.xml","form_type":"4"}},{"id":3612455,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & Operations Officer"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2019-03-05T16:49:32.000Z","date":"2019-03-01","kind":"sale","acquired":false,"shares":6575,"price":31.4256,"value":206623.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, the reporting person exercised this option, and sold the underlying shares, because the option was in the money and scheduled to expire on May 13, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.35 to $31.55, inclusive.  The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group  N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 20,731 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 21,751 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."}],"balance_after":125209,"source":{"system":"sec-edgar","filing":"0001235802-19-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000022/primary_doc.xml","form_type":"4"}},{"id":3612454,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & Operations Officer"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2019-03-05T16:49:32.000Z","date":"2019-03-01","kind":"exercise","acquired":true,"shares":6575,"price":15.01,"value":98690.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, the reporting person exercised this option, and sold the underlying shares, because the option was in the money and scheduled to expire on May 13, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount in this column was decreased by two shares from the reporting person's previous Form 4 reports due to a clerical error."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 20,731 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 21,751 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."}],"balance_after":131784,"source":{"system":"sec-edgar","filing":"0001235802-19-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580219000022/primary_doc.xml","form_type":"4"}},{"id":3838291,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP and CFO"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2018-08-20T16:30:12.000Z","date":"2018-08-16","kind":"sale","acquired":false,"shares":1182,"price":27.1877,"value":32135.8614,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 20,731 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 21,751 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."}],"balance_after":125211,"source":{"system":"sec-edgar","filing":"0001235802-18-000128","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580218000128/primary_doc.xml","form_type":"4"}},{"id":3860837,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President and CFO"}}],"security":"Stock Option (right to buy)","published_at":"2018-07-26T16:21:33.000Z","date":"2018-07-24","kind":"grant","acquired":true,"shares":36377,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests with respect to 25% of the shares on July 24, 2019 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments."}],"balance_after":36377,"derivative":{"exercise_price":24.49,"expiration_date":"2028-07-24","underlying":"Ordinary Shares","underlying_shares":36377},"source":{"system":"sec-edgar","filing":"0001235802-18-000103","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580218000103/primary_doc.xml","form_type":"4"}},{"id":3860836,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President and CFO"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2018-07-26T16:21:33.000Z","date":"2018-07-24","kind":"grant","acquired":true,"shares":13558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These ordinary shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 20,731 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 24,481 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."}],"balance_after":126393,"source":{"system":"sec-edgar","filing":"0001235802-18-000103","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580218000103/primary_doc.xml","form_type":"4"}},{"id":3903421,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and CFO"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2018-06-06T16:05:54.000Z","date":"2018-06-04","kind":"sale","acquired":false,"shares":6683,"price":24.61,"value":164468.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $24.45 to $24.84, inclusive.  The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group  N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 20,731 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 10,923 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."}],"balance_after":112835,"source":{"system":"sec-edgar","filing":"0001235802-18-000071","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580218000071/primary_doc.xml","form_type":"4"}},{"id":4251039,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP and CFO"}}],"security":"Stock Option (right to buy)","published_at":"2017-07-26T19:11:39.000Z","date":"2017-07-25","kind":"grant","acquired":true,"shares":32247,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests with respect to 25% of the shares on July 25, 2018 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments."}],"balance_after":32247,"derivative":{"exercise_price":27.86,"expiration_date":"2027-07-25","underlying":"Ordinary Shares","underlying_shares":32247},"source":{"system":"sec-edgar","filing":"0001235802-17-000136","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580217000136/primary_doc.xml","form_type":"4"}},{"id":4251038,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP and CFO"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2017-07-26T19:11:39.000Z","date":"2017-07-25","kind":"grant","acquired":true,"shares":10923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These ordinary shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 36,171 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 10,923 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan."}],"balance_after":119518,"source":{"system":"sec-edgar","filing":"0001235802-17-000136","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580217000136/primary_doc.xml","form_type":"4"}},{"id":4291070,"issuer":{"id":145358,"kind":"organization","name":"Wright Medical Group N.V.","symbol":"WMGI"},"owners":[{"id":23125,"kind":"person","name":"Berry Lance A","position":1,"cik":"0001478716","reported_name":"Berry Lance A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President and CFO"}}],"security":"Ordinary Shares, par value EUR 0.03 per share","published_at":"2017-06-06T16:19:17.000Z","date":"2017-06-02","kind":"sale","acquired":false,"shares":6685,"price":27.14,"value":181430.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $27.00 to $27.26, inclusive.  The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group  N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 36,171 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan."}],"balance_after":108595,"source":{"system":"sec-edgar","filing":"0001235802-17-000063","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492658/000123580217000063/primary_doc.xml","form_type":"4"}}]}